CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, 1138
N. diseases: 110; N. variants: 40
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
15 | 78578461 | intron variant | C/T | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
0.827 | 0.200 | 15 | 78573083 | intron variant | T/A;C | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.200 | 15 | 78573083 | intron variant | T/A;C | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.827 | 0.200 | 15 | 78573083 | intron variant | T/A;C | snv |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.827 | 0.200 | 15 | 78573083 | intron variant | T/A;C | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.200 | 15 | 78573083 | intron variant | T/A;C | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.827 | 0.200 | 15 | 78573083 | intron variant | T/A;C | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.040 | 15 | 78577237 | intron variant | T/A;G | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 0.080 | 15 | 78593646 | 3 prime UTR variant | T/C | snv | 0.64 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
15 | 78581634 | intron variant | T/A | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
15 | 78581634 | intron variant | T/A | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
0.925 | 0.080 | 15 | 78573551 | intron variant | G/A;C | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.080 | 15 | 78573551 | intron variant | G/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
1.000 | 0.080 | 15 | 78595490 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 15 | 78595490 | 3 prime UTR variant | A/G;T | snv |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 15 | 78595490 | 3 prime UTR variant | A/G;T | snv |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
15 | 78570420 | intron variant | G/A;C;T | snv |
|
0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||||
|
15 | 78570420 | intron variant | G/A;C;T | snv |
|
0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||||
|
0.790 | 0.120 | 15 | 78571130 | intron variant | T/C | snv | 0.28 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.790 | 0.120 | 15 | 78571130 | intron variant | T/C | snv | 0.28 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.790 | 0.120 | 15 | 78571130 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.120 | 15 | 78571130 | intron variant | T/C | snv | 0.28 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.790 | 0.120 | 15 | 78571130 | intron variant | T/C | snv | 0.28 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.790 | 0.120 | 15 | 78571130 | intron variant | T/C | snv | 0.28 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.790 | 0.120 | 15 | 78571130 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2015 | 2015 |